BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 09/08/1999

FDA Proposes Changes to Cardiopulmonary Bypass Devices

The FDA is proposing to reclassify cardiopulmonary bypass accessory equipment, goniometer devices, and electrode cable devices from Class I to Class II, and exempt them from premarket notification requirements, citing new information and a need for regulatory controls to ensure safety and effectiveness.

Source: Federal Register — Food and Drug AdministrationOpen original release →